Study guide
IIH diagnosis and vision protection
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
IIH diagnosis and vision protection
Key Takeaways Explain This Topic AI
IIH requires the complete clinical, imaging and CSF assessment after secondary causes are excluded.
Weight management can modify disease, while pressure medication and monitoring are selected for vision and tolerability.
Rapid visual deterioration can require surgery without severe headache; headache alone generally does not justify CSF diversion.
Last updated: October 2026
Idiopathic Intracranial Hypertension (IIH)
Idiopathic Intracranial Hypertension (IIH), historically termed pseudotumour cerebri or benign intracranial hypertension, is a clinical syndrome characterized by elevated intracranial pressure in the absence of a space-occupying lesion, hydrocephalus, or intracranial venous thrombosis.
Epidemiology & Risk Factors
Demographics: Overwhelmingly affects overweight females of childbearing age (aged 15 to 45 years; female-to-male ratio 8:1; BMI > 30 kg/m 2 >30\text{ kg/m}^2 > 30 kg/m 2 ). The annual incidence is approximately 1 to 2 per 100,000 in the general population, but surges to 15 to 20 per 100,000 in obese young women .
Weight Gain: Recent rapid weight gain (a 5% to 15% increase in total body weight over preceding months) is the most potent trigger.
Associated Pharmacological Agents: Tetracyclines (minocycline, doxycycline), excess vitamin A and retinoids (isotretinoin), recombinant human growth hormone, anabolic steroids, lithium, and abrupt withdrawal of chronic systemic corticosteroids.
The Modified Dandy Diagnostic Criteria
The diagnosis of IIH requires satisfying all components of the updated Modified Dandy Criteria:
Signs and symptoms of raised intracranial pressure (headache, papilloedema, TVOs, pulsatile tinnitus).
Absence of localising neurological signs, with the sole exception of unilateral or bilateral cranial nerve VI (abducens) palsy .
Completely normal cerebrospinal fluid (CSF) composition (normal protein, glucose, white blood cell count, and cytology).
Documented elevated CSF opening pressure measured on lumbar puncture performed in the lateral decubitus position :
Adults: > 25 cm H 2 O >25\text{ cm H}_2\text{O} > 25 cm H 2 O ( > 250 mm H 2 O >250\text{ mm H}_2\text{O} > 250 mm H 2 O ).
Children / non-obese: > 28 cm H 2 O >28\text{ cm H}_2\text{O} > 28 cm H 2 O in sedated or obese children; > 20 − 25 cm H 2 O >20-25\text{ cm H}_2\text{O} > 20 − 25 cm H 2 O in non-obese children.
Normal neuroimaging (MRI brain with contrast and MR Venography [MRV]): exclusion of mass lesions, hydrocephalus, meningeal enhancement, or cerebral venous sinus thrombosis.
Neuroimaging Biomarkers of Raised ICP on MRI / MRV
High-resolution MRI and MRV demonstrate characteristic neuro-radiological signs of elevated ICP in IIH:
Partially Empty or Empty Sella Turcica: Herniation of the suprasellar CSF-filled arachnoid space through an incompetent diaphragma sellae, flattening the pituitary gland against the sella floor.
Flattening of the Posterior Sclera / Posterior Globe: Mechanical indentation of the globe at the optic nerve insertion.
Distension of the Perioptic Subarachnoid Space: Prominent "cuff" of CSF fluid widening the retrobulbar optic nerve sheath.
Vertical Tortuosity of the Intraorbital Optic Nerve: Redundant, kinked optic nerve course.
Bilateral Transverse Cerebral Venous Sinus Stenosis: Smooth, tapering narrowing of the distal transverse sinuses on MRV.
- Evidence-Based Management of IIH
- 1. Medical Therapy & Lifestyle Modification
Structured Weight Loss: Weight reduction is the single disease-modifying intervention. A reduction of 5% to 10% of total body weight routinely induces complete clinical remission, lowering ICP and resolving papilloedema.
Acetazolamide (Diamox): First-line medical pharmacotherapy, validated by the landmark Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) . Acetazolamide is an oral carbonic anhydrase inhibitor (CAI) that acts on the choroid plexus epithelium, reducing CSF production by up to 50%. The starting dose is 500 mg to 1,000 mg daily in divided doses, titrated up to 2 to 4 g/day based on tolerance and visual field response. Side effects include distal paraesthesias (fingers and toes), dysgeusia (metallic taste with carbonated drinks), lethargy, hypokalaemia, metabolic acidosis, and nephrolithiasis.
Topiramate: An antiepileptic agent possessing weak carbonic anhydrase inhibitory properties, coupled with significant appetite suppression that aids weight loss and migraine-like headache prophylaxis; utilized as an alternative or adjunct to acetazolamide.
2. Surgical Interventions for Visual Threat
Surgical intervention is indicated in patients with progressive visual field deterioration despite maximal medical therapy , fulminant IIH (rapid visual acuity and field loss over days), or severe drug intolerance:
Optic Nerve Sheath Fenestration (ONSF): Surgical creation of slits or a window in the retrobulbar dural sheath behind the globe, decompressing the perioptic space and allowing CSF egress into the orbital fat. Highly effective for rapid resolution of disc swelling and visual field stabilization; preferred when visual preservation is the primary clinical objective and headaches are mild.
CSF diversion: Ventriculoperitoneal or lumboperitoneal shunting can protect vision when intracranial-pressure disease causes deterioration. Severe headache is not a required accompanying feature, and headache alone is generally not an indication. Discuss obstruction, infection, overdrainage and possible revisions with the specialist team.
Venous sinus stenting: A selected specialist option after anatomical and physiological assessment. A pressure gradient can inform selection but is not a universal standalone threshold. Evidence limits, antiplatelet requirements and procedural complications must be discussed.
Case: treating pressure while protecting vision
A patient with papilloedema has mild headache but worsening fields. Repeat reliable acuity and field assessment, document the discs, and assess the neurological investigation and pressure diagnosis. Headache severity is not a substitute for visual-risk assessment. A transient improvement after lumbar puncture does not establish durable control or justify repeated punctures as the sole long-term strategy. Medical treatment and weight management address different parts of care, while rapidly threatened vision may need urgent surgical discussion. Follow visual function and disc change closely enough to identify deterioration; avoid interpreting reduced swelling as recovery if optic atrophy is developing. Conversely, headache persisting after papilloedema resolves may need a separate headache plan. The exam answer should identify the immediate visual threat, the secondary causes already excluded and the next action, rather than only naming an intracranial-pressure drug.
Sections you finish are checked off in the contents.
- Up Next
- Disc drusen and pseudopapilloedema
- Continue learning